Inotec AMD is a Cambridge-based company that was founded to develop and launch an innovative technology to the global wound-care market. NATROX Oxygen Wound Therapy is an innovative, clinically proven and simple device that delivers 98% pure humidified oxygen directly to the wound bed, thus stimulating and improving wound healing.
The presence of a wound increases the body's need for oxygen: by 20% for a patient with a non-infected wound and 50% for a patient with an infected wound. Oxygen is critical to many of the processes required in wound healing, including:
Most wounds will demonstrate a degree of hypoxia due to tissue damage inherent with a wound; however, if oxygen demand continues to outstrip supply, this will result in compromised healing.
NATROX is an approved Class IIb medical device in all major markets, which enables clinicians to prescribe 98% pure humidified oxygen at 13ml/h directly to the wound bed to assist in all aspects of the wound healing process. The NATROX Oxygen Wound Therapy system comprises an oxygen generator and an oxygen delivery system. The generator comes with two interchangeable and rechargeable batteries.
As NATROX is about the size of a mobile phone, battery operated and therefore completely portable and totally silent, this active therapy can be maintained 24 hours a day, seven days a week until the wound heals. In a recent pilot study conducted in Cambridge and London, UK, patients rated the acceptability of using the device night and day, giving it an overall score of 9.9/10. With a growing body of clinical evidence supporting the use of NATROX in a variety of wounds and excellent patient feedback, NATROX is set to improve wound care globally.